The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

7 articles for JH No


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Multitarget drug discovery for tuberculosis and other infectious diseases.EBI
University of Illinois At Urbana-Champaign
Chemo-Immunotherapeutic Anti-Malarials Targeting Isoprenoid Biosynthesis.EBI
Prenylx Research Institute
Lipophilic bisphosphonates are potent inhibitors of Plasmodium liver-stage growth.EBI
National Institute of Immunology
Inhibition of staphyloxanthin virulence factor biosynthesis in Staphylococcus aureus: in vitro, in vivo, and crystallographic results.EBI
University of Illinois At Urbana-Champaign
Inhibition of the Fe(4)S(4)-cluster-containing protein IspH (LytB): electron paramagnetic resonance, metallacycles, and mechanisms.EBI
University of Illinois At Urbana-Champaign
Pharmaceutical compositions comprising RET inhibitors and methods for the treatment of cancerBDB
Queen'S University At Kingston
N-benzylisatin sulfonamide analogues as potent caspase-3 inhibitors: synthesis, in vitro activity, and molecular modeling studies.BDB
Washington University